We are live on ! Find out more
WC

Woodstock Corp Portfolio holdings

AUM $1.2B
1-Year Est. Return 26.37%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+26.37%
3 Year Est. Return
+96.13%
5 Year Est. Return
+140.78%
10 Year Est. Return
+511.59%
AUM
$614M
AUM Growth
+$40M
Cap. Flow
-$7.96M
Cap. Flow %
-1.3%
Top 10 Hldgs %
29.7%
Holding
164
New
2
Increased
37
Reduced
65
Closed
9

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.57M
2
IRM icon
Iron Mountain
IRM
+$626K
3
MMM icon
3M
MMM
+$589K
4
KYNB
Kyntra Bio
KYNB
+$490K
5
RTN
Raytheon Company
RTN
+$442K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$9.2M
2
SLB icon
SLB Ltd
SLB
+$1.83M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$1.01M
4
HAIN icon
Hain Celestial
HAIN
+$727K
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$605K

Sector Composition

Rank Sector Weight
1 Healthcare 24.16%
2 Technology 22.86%
3 Industrials 9.44%
4 Consumer Staples 8.89%
5 Communication Services 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBIX icon
76
Neurocrine Biosciences
NBIX
$16.4B
$1.6M 0.26%
14,880
– –
HDV
77
iShares Core High Dividend ETF
HDV
$14.8B
$1.59M 0.26%
80,900
– –
T icon
78
AT&T
T
$162B
$1.59M 0.26%
53,729
-3,991
-7% -$115K
IRM icon
79
Iron Mountain
IRM
$36.2B
$1.56M 0.25%
48,859
+19,102
+64% +$626K
VWO icon
80
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$1.54M 0.25%
34,652
+1,900
+6% +$80.5K
AYX
81
DELISTED
Alteryx Inc
AYX
$1.53M 0.25%
15,269
– –
BP icon
82
BP
BP
$108B
$1.37M 0.22%
36,410
-150
-0.4% -$5.7K
GE icon
83
GE Aerospace
GE
$390B
$1.34M 0.22%
24,090
-876
-4% -$45.3K
RDS.A
84
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.28M 0.21%
21,737
-503
-2% -$29.4K
MDY icon
85
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$1.26M 0.2%
3,352
– –
EPZM
86
DELISTED
Epizyme, Inc
EPZM
$1.18M 0.19%
48,098
+11,019
+30% +$164K
AXP icon
87
American Express
AXP
$232B
$1.11M 0.18%
8,932
-410
-4% -$49K
SO icon
88
Southern Company
SO
$106B
$1.1M 0.18%
17,326
-50
-0.3% -$3.1K
WBA
89
DELISTED
Walgreens Boots Alliance
WBA
$1.1M 0.18%
18,682
-2,092
-10% -$121K
SPGI icon
90
S&P Global
SPGI
$119B
$1.06M 0.17%
3,900
-470
-11% -$122K
MKC icon
91
McCormick & Company Non-Voting
MKC
$13.9B
$1.06M 0.17%
12,520
-60
-0.5% -$4.96K
BA icon
92
Boeing
BA
$183B
$1.03M 0.17%
3,169
-105
-3% -$37.2K
KYNB
93
Kyntra Bio
KYNB
$28.3M
$944K 0.15%
881
+480
+120% +$490K
VRTX icon
94
Vertex Pharmaceuticals
VRTX
$123B
$939K 0.15%
4,289
– –
VEA icon
95
Vanguard FTSE Developed Markets ETF
VEA
$234B
$935K 0.15%
21,224
– –
AKAM icon
96
Akamai
AKAM
$17B
$925K 0.15%
10,708
– –
IBM icon
97
IBM
IBM
$219B
$898K 0.15%
7,005
-704
-9% -$91.5K
BABA icon
98
Alibaba
BABA
$303B
$835K 0.14%
3,936
– –
OMC icon
99
Omnicom Group
OMC
$22.6B
$806K 0.13%
9,954
+19
+0.2% +$1.49K
CAT icon
100
Caterpillar
CAT
$400B
$799K 0.13%
5,413
-145
-3% -$20.2K
2 3
4
5 6

Similar funds

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return
MB
MidFirst Bank Oklahoma City, Oklahoma $1.21B AUM
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return

Woodstock Corp's Q4 2019 Portfolio in Review

As of Q4 2019, Woodstock Corp held 164 positions worth $614M, up 7% from $574M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Woodstock Corp's Q4 2019 filing shows 2 new, 37 increased, 65 reduced and 9 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 90,585 shares worth $273K. The largest sale was Celgene Corp, an estimated $9.2M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Woodstock Corp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 90,585 shares worth $273K.
  • Woodstock Corp added most to Bristol-Myers Squibb in Q4 2019, an estimated $5.57M increase.
  • Woodstock Corp's biggest Q4 2019 reduction was SLB Ltd, cutting an estimated $1.83M.
  • Woodstock Corp fully exited Celgene Corp in Q4 2019, selling an estimated $9.2M.
  • Woodstock Corp's ten largest holdings make up 30% of its $614M portfolio in Q4 2019.
  • Woodstock Corp opened 2 new positions and closed 9 in Q4 2019.
  • Woodstock Corp's portfolio value rose 7% quarter-over-quarter to $614M.

Based on Woodstock Corp's 13F filing for Q4 2019, filed 13 Jan 2020.